These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 440805)

  • 21. Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
    Levin M; Burns JC; Gordon JB
    Cardiology; 2014; 129(3):174-7. PubMed ID: 25300244
    [No Abstract]   [Full Text] [Related]  

  • 22. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.
    Sugahara Y; Ishii M; Muta H; Iemura M; Matsuishi T; Kato H
    Pediatr Cardiol; 2008 Mar; 29(2):398-401. PubMed ID: 18027010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mucocutaneous lymph node syndrome or Kawasaki disease].
    Zulaíca D; Ruíz M; Alba A; Higes A; Damiano A
    Rev Clin Esp; 1981 Nov; 163(4):217-20. PubMed ID: 7038786
    [No Abstract]   [Full Text] [Related]  

  • 25. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.
    Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR
    Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
    Suda K
    Nihon Rinsho; 2014 Sep; 72(9):1659-63. PubMed ID: 25518419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB; Falcini F; Favilli S; Pollini I; Capuzzo L; Simonini G; De Simone L
    Pediatr Med Chir; 2002; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease.
    Koren G; Rose V; Lavi S; Rowe R
    JAMA; 1985 Aug; 254(6):767-9. PubMed ID: 4009911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
    Suda K; Kudo Y; Higaki T; Nomura Y; Miura M; Matsumura M; Ayusawa M; Ogawa S; Matsuishi T
    Circ J; 2009 Jul; 73(7):1319-23. PubMed ID: 19436123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac and coronary arterial involvement in infants and children from New England with mucocutaneous lymph node syndrome (Kawasaki disease). Angiocardiographic-echocardiographic correlations.
    Chung KJ; Brandt L; Fulton DR; Kreidberg MB
    Am J Cardiol; 1982 Jul; 50(1):136-42. PubMed ID: 7090996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
    J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary heart disease in children with Kawasaki disease.
    Kato H; Koike S; Tanaka C; Yokochi K; Yoshioka F; Takeuchi S; Matsunaga S; Yokoyama T
    Jpn Circ J; 1979 May; 43(5):469-75. PubMed ID: 470108
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mucocutaneous lymph node syndrome (Kawasaki disease) in adults].
    Horstmann E; Daweke H
    MMW Munch Med Wochenschr; 1982 Oct; 124(42):909-10. PubMed ID: 6819459
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
    Lilje C; Joyce JJ
    Circulation; 2005 Jun; 111(24):e440. PubMed ID: 15967855
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coronary aneurysm following Kawasaki syndrome].
    Engelhardt W; Mühler E; Keutel J; Kluitmann G; Oberhoffer R; Hofstetter R; von Bernuth G
    Z Kardiol; 1990 May; 79(5):336-40. PubMed ID: 2382462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
    Loomba RS
    Cardiology; 2015; 130(3):164-5. PubMed ID: 25676566
    [No Abstract]   [Full Text] [Related]  

  • 40. Kawasaki disease, or mucocutaneous lymph node syndrome: report of seven cases in North America.
    Teixeira OH; Martin L; Carpenter BF; Sellers FJ
    Can Med Assoc J; 1980 May; 122(9):1013-8. PubMed ID: 7370880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.